10.1002/ejoc.202000365
European Journal of Organic Chemistry
FULL PAPER
mmol), propiophenone 4g (90 mg, 0.67 mmol), KOH (38 mg, 0.67 mg) in
DMSO (1.0 mL) at 80 °C and subsequent stirring for 7 h. The crude
product was purified by neutral alumina column chromatography (10%
ethyl acetate in hexane) to afford the desired product 3x as colourless
liquid (89 mg, 61%). Analytical data of 3x: 1H NMR (500 MHz, CDCl3,
T ) δ 8 13 (d, J = 8 Hz, 1H), 8.00 (s, 1H), 7.76 (d, J = 8 Hz, 1H),
7 67−7 64 (m, 1H), 7 58 (d, J = 7 Hz, 2H), 7 52−7 47 (m, 3H), 7 44-7.41
(m, 1H), 2.45 (s, 3H) ppm. 13C{1H} NMR (125 MHz, CDCl3) δ 16 6,
146.6, 140.9, 136.8, 129.3, 129.2, 128.9, 128.8, 128.3, 128.2, 127.6,
126.8, 126.4, 20.7 ppm. HRMS (ESI-Orbitrap) m/z: (M+H)+ calcd for
C16H14N 220.1121, found 220.1134.
21.4, 18.7, 12.0, 11.7 ppm. HRMS (ESI-Orbitrap) m/z: (M+ H)+ calcd for
C17H22N 472.3938, found 472.3962.
4-methyl-2-phenylquinoline
(3ad).[14g]
Following
the
general
experimental procedure with 1-(2-aminophenyl)ethan-1-ol 1b (110 mg,
80 mmol), acetophenone 2b (81 mg, 0.67 mmol), KOH (38 mg, 0.67
mmol) in DMSO (1.0 mL) at 80 °C and subsequent stirring for 7 h. The
crude product was purified by neutral alumina column chromatography
(10% ethyl acetate in hexane) to afford the desired product 3ad as a pale
yellow solid (110 mg, 75%). Analytical data of 3ad: 1H NMR (300 MHz,
CDCl3, T ) δ 8 31 – 8.24 (m, 3H), 7.99 (d, J = 8.7 Hz, 1H), 7.80– 7.75
(m, 1H), 7.72 (s, 1H), 7.62 – 7.53 (m, 4H), 2.74 (s, 3H) ppm. 13C{1H}
NMR (75 MHz, CDCl3) δ 156 8, 147 9, 144 6, 139 6, 13 1, 129 1, 129 ,
128.6, 127.4, 127.0, 125.8, 123.4, 119.5, 18.8 ppm.
3-ethyl-2-phenylquinoline (3y).[14a] Following the general experimental
procedure with o-aminobenzylalcohol 1a (99 mg,0.80 mmol),
butyrophenone 4h (99 mg, 0.67 mmol), KOH (38 mg, 0.67 mmol) in
DMSO (1.0 mL) at 80 °C and subsequent stirring for 7 h. The crude
product was purified by neutral alumina column chromatography (10%
ethyl acetate in hexanes) to afford the desired product 3y as colourless
liquid (90 mg, 58%). Analytical data of 3y: 1H NMR (500 MHz, CDCl3,
T ) δ 8 13 (d, J = 8.5 Hz, 1H), 8.06 (s, 1H), 7.82 (d, J = 8 Hz, 1H),
7 68−7 65 (m, 1H), 7 56−7 53 (m, 3H), 7 5 −7 42 (m, 3H), 2 9 (q, J =
7.5 Hz,2H), 1.20 (t, J = 7.5Hz, 3H) ppm. 13C{1H} NMR (125 MHz, CDCl3)
δ 16 7, 146 4, 14 9, 135.3, 134.9, 129.3, 128.8, 128.7, 128.3, 128.1,
127.8, 127.0, 126.4, 26.0, 14.7 ppm. HRMS (ESI-Orbitrap) m/z: (M+H)+
calcd for C17H16N 234.1277, found 234.1283.
2,4-diphenylquinoline (3ae).[14g] Following the general experimental
procedure with (2-aminophenyl)(phenyl)methanol 1c (159 mg, 0.80
mmol), acetophenone 2b (81 mg, 0.67 mmol), KOH (38 mg, 0.67 mmol)
in DMSO (1.0 mL) at 80 °C and subsequent stirring for 7 h. The crude
product was purified by neutral alumina column chromatography (10%
ethyl acetate in hexane) to afford the desired product 3ae as a pale
yellow solid (135 mg, 72%). Analytical data of 3ae: 1H NMR (300 MHz,
CDCl3, T ) δ 8 27 (d, J = 8.4 Hz, 1H), 8.22 – 8.20 (m, 2H), 7.92 (d, J =
8.7 Hz, 1H), 7.83 (s, 1H), 7.77 – 7.72 (m, 1H), 7.58 – 7.46 (m, 9H) ppm.
13C{1H} NMR (75 MHz, CDCl3) δ 156 9, 149 2, 148.8, 139.6, 138.4, 130.1,
129.6, 129.4, 128.8, 128.6, 128.4, 127.6, 126.3, 125.8, 125.6, 119.4 ppm.
4-isopropyl-1-methyl-1,2,3,4-tetrahydroacridine (3ab). Following the
general experimental procedure with o-aminobenzylalcohol 1a (99 mg,
0.80 mmol), menthone (isomeric mixture) 4i (104 mg, 0.67 mmol), KOH
(38 mg, 0.67 mmol) in DMSO (1.0 mL) at 80 °C and subsequent stirring
for 7h. The crude product was purified by neutral alumina column
chromatography (10% ethyl acetate in hexanes) to afford the desired
product 3ab as a colourless liquid and as an isomeric mixture (ratio 2:1)
(109 mg, 68%). Analytical data of 3ab: 1H NMR (500 MHz, CDCl3, TMS)
δ 7 99 (d, J = 8.5 Hz,1.5 H), 7.94 (s, 0.53H), 7.85 (s, 1H), 7.72 (t, J = 8.5
Hz, 1.5H), 7.60 (t, J = 7Hz, 1.54H), 7.43 (t, J = 7 Hz, 1 54H), 3 13−3 7
(m, 1.62H), 3.02 – 2 95 (m, 3 17H), 2 6−2 4 (m, 1 2H), 1 94−1 85 (m,
3 3 H), 1 76−1 74 (m, 1 63H), 1 41 (d, J = 6.5 Hz, 1.6H), 1.37 (d, J = 7
Hz, 3.08H), 1.11 (d, J = 6.5 Hz, 3.04H), 1.07 (d, J = 7 Hz, 1.70H), 0.75 (d,
J = 6.5 Hz, 3.00H), 0.67 (d, J = 6.5 Hz, 1.63H) ppm. 13C{1H} NMR (125
MHz, CDCl3) δ 162 , 161 7, 146 7, 146 4, 137 1, 136 8, 134 2, 132 4,
128.7, 128.5, 128.3, 128.2, 127.1, 126.9, 126.8, 125.4, 47.6, 47.0, 33.3,
32.9, 31.4, 31.3, 30.5, 28.6, 23.1, 21.8, 21.2, 21.0, 20.8, 18.7, 17.5, 17.0
ppm. HRMS (ESI-Orbitrap) m/z: (M+H)+ calcd for C17H22N 240.1747,
found 240.1752.
8-methyl-2-phenylquinoline
(3af).[14a]
Following
the
general
experimental procedure with (2-amino-3-methylphenyl)methanol 1d (110
mg, 0.80 mmol), acetophenone 2b (81 mg, 0.67 mmol), KOH (37.5 mg,
0.67 mmol) in DMSO (1.0 mL) at 80 °C and subsequent stirring for 7 h.
The crude product was purified by neutral alumina column
chromatography (10% ethyl acetate in hexane) to afford the desired
product 3af as a pale yellow solid (126 mg, 86%). Analytical data of 3af:
1H NMR (300 MHz, CDCl3, T ) δ 8 29−8 26 (m, 2H), 8 19 (d, J = 8.4
Hz, 1H), 7.91 (d, J = 8.4 Hz, 1H), 7.67 (d, J = 8.1 Hz, 1H), 7.59 – 7.56 (m,
1H), 7 54−7 51 (m, 2H), 7 49−7 45 (m, 1H) 7 44−7 39 (m, 1H), 2 92 (s,
3H) ppm. 13C{1H} NMR (75 MHz, CDCl3) δ 155 5, 147 1, 139 8, 137 7,
137.0, 129.7, 129.2, 128.8, 127.5, 127.1, 126.0, 125.4, 118.2, 17.9 ppm.
2-phenyl-4-(trifluoromethyl)quinoline (3ag). Following the general
experimental procedure with 1-(2-aminophenyl)-2,2,2-trifluoroethan-1-ol
1e (151 mg, 0.80 mmol), acetophenone 2b (81 mg, 0.67 mmol), KOH
(37.5 mg, 0.67 mmol) in DMSO (1.0 mL) at 80 °C and subsequent stirring
for 7 h. The crude product was purified by neutral alumina column
chromatography (5% ethyl acetate in hexane) to afford the desired
product 3ag as a white solid, 135 mg (74%). Analytical data of 3ag: 1H
NMR (500 MHz, CDCl3, T ) δ 8 3 (d, J = 8 Hz, 1H), 8 23−8 20 (m, 3H),
8.17 (d, J = 8.5 Hz, 1H), 7.85 (t, J = 7.5 Hz, 1H), 7.69 (t, J = 8 Hz, 1H),
7.60-7.52 (m, 3H) ppm. 13C{1H} NMR (125 MHz, CDCl3) δ 156 7, 149 2,
138.5, 130.7, 130.4, 130.0 129.0, 127.9, 127.5, 123.9 (q, J = 2.5 Hz ),
116.0(q, J = 1.3Hz) ppm. HRMS (ESI-Orbitrap) m/z: (M+H)+ calcd for
C16H11F3N 274.0838, found 274.0842.
(3aS,3bR,13S,13bS,15aR)-13,15a-dimethyl-1-(6-methylheptan-2-yl)-
2,3,3a,3b,4,5,5a,6,13,13a,13b,14,15,15a-tetradecahydro-1H-
cyclopenta[5,6]naphtho[1,2-b]acridine (3ac). Following the general
experimental procedure with o-aminobenzylalcohol 1a (99 mg, 0.80
mmol), cholestan-3-one 4j (260 mg, 0.67 mmol), KOH (38 mg, 0.67
mmol) in DMSO (1.0 mL) at 80 °C and subsequent stirring for 7 h. The
crude product was purified by neutral alumina column chromatography
(10% ethyl acetate in hexane) to afford the desired product 3ac as white
solid (88 mg, 28%). Analytical data of 3ac: p: 183−186 °C 1H NMR
(500 MHz, CDCl3, T ) δ 7 97 (d, J = 8.5 Hz, 1H), 7.81 (s, 1H), 7.70 (d,
J = 8 Hz, 1H), 7.60 (t, J = 7.5 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 3.08 (dd,
J1 = 18 Hz, J2 = 5.0 Hz, 1H), 2.99 (d, J = 16 Hz, 2H), 2.79 (dd, J1 = 18 Hz,
J2 = 13 Hz, 1H), 2.61 (d, J = 16.0 Hz, 1H), 2.06 (d, J = 12 Hz, 1H),
1 88−1 75 (m, 3H), 1 67−1 62 (m, 5H), 1 54−1 47 (m, 2H), 1 4 −1 34 (m,
4H), 1 28−1 21 (m, 2H), 1 15−1 4 (m, 6H), 1 2− 98(m, 2H), 94 (d, J
= 6 Hz, 3H), 0.87 (d, J = 6 Hz, 6H), 0.80 (s, 3H), 0.70 (s, 3H) ppm.
13C{1H} NMR (125 MHz, CDCl3) δ 158 6, 146 7, 135 7, 13 3, 128 5,
128.3, 127.3, 126.8, 125.4, 56.5, 56.4, 53.6, 43.6, 42.5, 42.3, 40.0, 39.5,
37.5, 36.2, 35.8, 35.6, 35.3, 31.7, 28.8, 28.3, 28.2, 24.3, 23.9, 22.8, 22.6,
(2-((1-phenylethylidene)amino)phenyl)methanol (5). The imine
intermediate was synthesized by treating o-aminobenzylalcohol 1a (200
mg, 1.62 mmol), acetophenone 2b (194 mg, 1.62 mmol) in benzene (5.0
mL) at 100 °C during which water was removed by azeotropic distillation.
After 12 h, the reaction mixture was allowed to cool and the precipitate
formed was filtered and purified by washing with benzene to afford the
desired product 5 as a white solid (218 mg, 60%). Analytical data of 5: 1H
NMR (500 MHz, Acetone-d6, T ) δ 8 22 (d, J = 8.5 Hz, 1H), 8.16 (d, J =
8.5 Hz, 2H), 7.93 (d, J = 8.5 Hz, 2H), 7.80 (d, J = 8. Hz, 2H), 7.62 (t, J =
7.5. Hz, 1H), 7.41 (t, J = 7.5. Hz, H), 6.97(d, J = 8 Hz, 2H), 3.76 (s, 2H),
1.92 (s, 3H) ppm. 13C{1H} NMR (125 MHz, CDCl3) δ 161 2, 156 3, 148 3,
This article is protected by copyright. All rights reserved.